HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greene, J. L. Articles by Linsley, P. S. Search for Related Content PubMed PubMed Citation Articles by Greene, J. L. Articles by Linsley, P. S. Social Bookmarking                      What's this?

Volume 271, Number 43, Issue of October 25, 1996 pp. 26762-26771
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions

(Received for publication, April 23, 1996, and in revised form, July 23, 1996)

From the Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121

T lymphocyte receptors CD28 and CTLA-4 bind costimulatory molecules CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells and regulate T cell activation. While distinct functional roles have been ascribed to each of these molecules, little is known about how they interact. To better characterize these interactions, we have used surface plasmon resonance to perform equilibrium and kinetic binding analyses of extracellular fragments of CD28/CTLA-4/CD80/CD86. We show that CTLA-4 and CD28 binding are both characterized by rapid kinetic on-rates and rapid dissociation rates. Native disulfide-linked homodimers of CD28 and CTLA-4 bound with two kinetically distinct binding sites, one of high avidity and slow dissociation and one of low avidity and more rapid dissociation. Monomeric CTLA-4 bound only with low affinity and rapid dissociation. Therefore, covalent dimerization of CTLA-4 is required for its high avidity binding. Oligomerization of CD80/CD86 is also required for high avidity CTLA-4 binding since CTLA-4 bound with low avidity to monomeric CD86. This contrasts with the ability of CD80/CD86 on antigen-presenting cells to bind CTLA4Ig with high avidity and predicts their organization as oligomers or clusters that permit multivalent binding. Thus, covalent receptor dimerization and ligand oligomerization are two key features of the CD28/CTLA-4/CD80/CD86 receptor system that control ligand binding and may regulate signal transduction by controlling the duration of receptor occupancy.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Kim, O. Turovskaya, M. Levin, F. R. Byrne, J. S. Whoriskey, J. G. McCabe, and M. Kronenberg Spontaneous Colitis Occurrence in Transgenic Mice with Altered B7-Mediated Costimulation J. Immunol., October 15, 2008; 181(8): 5278 - 5288. [Abstract] [Full Text] [PDF]

				W.-H. Zhou, L. Dong, M.-R. Du, X.-Y. Zhu, and D.-J. Li Cyclosporin A improves murine pregnancy outcome in abortion-prone matings: involvement of CD80/86 and CD28/CTLA-4 Reproduction, March 1, 2008; 135(3): 385 - 395. [Abstract] [Full Text] [PDF]

				P. E. Fecci, H. Ochiai, D. A. Mitchell, P. M. Grossi, A. E. Sweeney, G. E. Archer, T. Cummings, J. P. Allison, D. D. Bigner, and J. H. Sampson Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function Clin. Cancer Res., April 1, 2007; 13(7): 2158 - 2167. [Abstract] [Full Text] [PDF]

				N. Wang, M. Campo, L. Ting, C. Fleming, C. Terhorst, and P. W. Finn The Costimulatory Molecule SLAM Is Critical for Pulmonary Allergic Responses Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 206 - 210. [Abstract] [Full Text] [PDF]

				S. Bhatia, M. Edidin, S. C. Almo, and S. G. Nathenson Different cell surface oligomeric states of B7-1 and B7-2: Implications for signaling PNAS, October 25, 2005; 102(43): 15569 - 15574. [Abstract] [Full Text] [PDF]

				S. Nierkens, M. Aalbers, M. Bol, R. Bleumink, P. van Kooten, L. Boon, and R. Pieters Differential Requirement for CD28/CTLA-4-CD80/CD86 Interactions in Drug-Induced Type 1 and Type 2 Immune Responses to Trinitrophenyl-Ovalbumin J. Immunol., September 15, 2005; 175(6): 3707 - 3714. [Abstract] [Full Text] [PDF]

				H. Kwon, H.-S. Jun, L.-Y. Khil, and J.-W. Yoon Role of CTLA-4 in the Activation of Single- and Double-Positive Thymocytes J. Immunol., December 1, 2004; 173(11): 6645 - 6653. [Abstract] [Full Text] [PDF]

				P. Sorensen, M. Kussmann, A. Rosen, K. L. Bennett, D. d. G. Thrige, K. Uvebrant, B. Walse, P. Roepstorff, and P. Bjork Identification of Protein-Protein Interfaces Implicated in CD80-CD28 Costimulatory Signaling J. Immunol., June 1, 2004; 172(11): 6803 - 6809. [Abstract] [Full Text] [PDF]

				D. H. Munn, M. D. Sharma, and A. L. Mellor Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells J. Immunol., April 1, 2004; 172(7): 4100 - 4110. [Abstract] [Full Text] [PDF]

				J. M. Kremer, R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig N. Engl. J. Med., November 13, 2003; 349(20): 1907 - 1915. [Abstract] [Full Text] [PDF]

				B. P. Nayak, G. Sailaja, and A. M. Jabbar Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4 J. Virol., October 15, 2003; 77(20): 10850 - 10861. [Abstract] [Full Text] [PDF]

				K. Sandstrom, Z. Xu, G. Forsberg, and P.-A. Nygren Inhibition of the CD28-CD80 co-stimulation signal by a CD28-binding affibody ligand developed by combinatorial protein engineering Protein Eng. Des. Sel., September 1, 2003; 16(9): 691 - 697. [Abstract] [Full Text] [PDF]

				X. Zhang, J.-C. D. Schwartz, S. C. Almo, and S. G. Nathenson Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling PNAS, March 4, 2003; 100(5): 2586 - 2591. [Abstract] [Full Text] [PDF]

				C. Vasu, A. Wang, S. R. Gorla, S. Kaithamana, B. S. Prabhakar, and M. J. Holterman CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties Int. Immunol., February 1, 2003; 15(2): 167 - 175. [Abstract] [Full Text] [PDF]

				J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 J. Immunol., September 1, 2002; 169(5): 2762 - 2771. [Abstract] [Full Text] [PDF]

				M. Srinivasan, I. E. Gienapp, S. S. Stuckman, C. J. Rogers, S. D. Jewell, P. T. P. Kaumaya, and C. C. Whitacre Suppression of Experimental Autoimmune Encephalomyelitis Using Peptide Mimics of CD28 J. Immunol., August 15, 2002; 169(4): 2180 - 2188. [Abstract] [Full Text] [PDF]

				T. J. Lang, P. Nguyen, R. Peach, W. C. Gause, and C. S. Via In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function J. Immunol., April 15, 2002; 168(8): 3786 - 3792. [Abstract] [Full Text] [PDF]

				K. Ohnuma, Y. Munakata, T. Ishii, S. Iwata, S. Kobayashi, O. Hosono, H. Kawasaki, N. H. Dang, and C. Morimoto Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs J. Immunol., December 15, 2001; 167(12): 6745 - 6755. [Abstract] [Full Text] [PDF]

				M. Srinivasan, R. M. Wardrop, I. E. Gienapp, S. S. Stuckman, C. C. Whitacre, and P. T. P. Kaumaya A Retro-Inverso Peptide Mimic of CD28 Encompassing the MYPPPY Motif Adopts a Polyproline Type II Helix and Inhibits Encephalitogenic T Cells In Vitro J. Immunol., July 1, 2001; 167(1): 578 - 585. [Abstract] [Full Text] [PDF]

				M. S. Kuhns, V. Epshteyn, R. A. Sobel, and J. P. Allison Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells PNAS, October 23, 2000; (2000) 220423597. [Abstract] [Full Text]

				L. BUGEON and M. J. DALLMAN Costimulation of T Cells Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S164 - 168. [Abstract] [Full Text] [PDF]

				V. Ling, P. W. Wu, H. F. Finnerty, K. M. Bean, V. Spaulding, L. A. Fouser, J. P. Leonard, S. E. Hunter, R. Zollner, J. L. Thomas, et al. Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor J. Immunol., February 15, 2000; 164(4): 1653 - 1657. [Abstract] [Full Text] [PDF]

				A. Martin-Fontecha, M. Moro, M. C. Crosti, F. Veglia, G. Casorati, and P. Dellabona Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity J. Immunol., January 15, 2000; 164(2): 698 - 704. [Abstract] [Full Text] [PDF]

				A. N. Vallejo, J. C. Brandes, C. M. Weyand, and J. J. Goronzy Modulation of CD28 Expression: Distinct Regulatory Pathways During Activation and Replicative Senescence J. Immunol., June 1, 1999; 162(11): 6572 - 6579. [Abstract] [Full Text] [PDF]

				C. Olsson, K. Riebeck, M. Dohlsten, and E. Michaelsson CTLA-4 Ligation Suppresses CD28-induced NF-kappa B and AP-1 Activity in Mouse T Cell Blasts J. Biol. Chem., May 14, 1999; 274(20): 14400 - 14405. [Abstract] [Full Text] [PDF]

				J. M. Slavik, J. E. Hutchcroft, and B. E. Bierer CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28 J. Biol. Chem., January 29, 1999; 274(5): 3116 - 3124. [Abstract] [Full Text] [PDF]

				T. Fukumoto, N. Torigoe, Y. Ito, Y. Kajiwara, and K. Sugimura T Cell Proliferation-Augmenting Activities of the Gene 3 Protein Derived from a Phage Library Clone with CD80-Binding Activity J. Immunol., December 15, 1998; 161(12): 6622 - 6628. [Abstract] [Full Text] [PDF]

				R. T. Doty and E. A. Clark Two Regions in the CD80 Cytoplasmic Tail Regulate CD80 Redistribution and T Cell Costimulation J. Immunol., September 15, 1998; 161(6): 2700 - 2707. [Abstract] [Full Text] [PDF]

				P.  A. van der Merwe, D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics J. Exp. Med., February 3, 1997; 185(3): 393 - 404. [Abstract] [Full Text] [PDF]

				I. D'Orso and A. C. C. Frasch TcUBP-1, a Developmentally Regulated U-rich RNA-binding Protein Involved in Selective mRNA Destabilization in Trypanosomes J. Biol. Chem., September 7, 2001; 276(37): 34801 - 34809. [Abstract] [Full Text] [PDF]

				G. Deliyannis, J. S. Boyle, J. L. Brady, L. E. Brown, and A. M. Lew A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge PNAS, June 6, 2000; 97(12): 6676 - 6680. [Abstract] [Full Text] [PDF]

				M. S. Kuhns, V. Epshteyn, R. A. Sobel, and J. P. Allison Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells PNAS, November 7, 2000; 97(23): 12711 - 12716. [Abstract] [Full Text] [PDF]